Blue Matter Blog

Blue Matter Again Ranked as One of the 25 Best Consulting Firms to Work for in Europe; Ranked #1 in 5 Categories
January 19, 2021

Last week, we reported that Blue Matter was ranked as one of the Top 50 consulting firms to work for in North America (#19).  Today, Vault released its rankings for Europe.  We’re thrilled to announce that we were ranked #11 among the best firms to work for in Europe, improving our position over last year! …

Blue Matter Consulting - DNA Strand and Cancer Cell - Oncology Cell Therapy
2021 Outlook for Cell-Based Therapies in Oncology: CAR-T Expansion and Beyond
January 14, 2021

One year ago when we published an in-depth review of the cell-based immunotherapy landscape, no one could have predicted the global COVID-19 pandemic and its associated disruptions. But researchers, drug developers, regulatory agencies, clinicians, and patients all worked hard to ensure that the cell therapy field continued to advance and deliver promising new treatments in …

Blue Matter Ranked for 2nd Year as One of the 50 Best Consulting Firms to Work for in North America
January 13, 2021

For the second time, Blue Matter has earned a spot in the annual Vault Consulting 50 list!  We’re excited to be ranked as one of the 50 best consulting firms to work for in North America.  Among all consulting firms surveyed, Blue Matter ranked #19, up from the #30 position last year.  Among boutique firms, …

Central Nervous System Therapies: Outlook for 2021 & Beyond
January 5, 2021

So far in this series, we’ve spent a great deal of time looking backward.  In part 1, we discussed the “quiet revolution” that has been taking place in CNS over the past several years.  Interesting advances are being made in a range of CNS therapies while other areas, such as oncology, tend to get more …